Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
Filing tables
Filing exhibits
Related press release
Associated CMMB transcripts
CMMB similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Chemomab Therapeutics Ltd.:
Chemomab Therapeutics Ltd.:
We consent to the incorporation by reference in the registration statements (No.333-255249 and No. 333-255659) on form S-3 and in the registration statement (No.333-259489) on form S-8 of our report dated March 30, 2022, with respect to the financial statements of Chemomab Therapeutics Ltd.
/s/ Somekh Chaikin Somekh Chaikin |
Member Firm of KPMG International |
Tel Aviv, Israel
March 30, 2022